Latest

AIM ImmunoTech Announces Further Efforts to Establish Clinical Trials Assessing Ampligen as a Potential Protective and Early-Onset Treatment for...

CEO Roadshow - March 26, 2020

AIM ImmunoTech Provides Comprehensive Clinical Trials Update With Major Inflection Points Identified

CEO Roadshow - October 7, 2019

Hemispherx Biopharma, Inc. Changes Name to AIM ImmunoTech Inc. Reflecting Ampligen’s® Immuno Modulation Progress in Ongoing Oncology Clinical Trials...

CEO Roadshow - August 23, 2019

AIM ImmunoTech News

Home AIM ImmunoTech AIM ImmunoTech News

AIM ImmunoTech News

Hemispherx Reports Positive Safety and Survival Data in Phase 1 Stage...

CEO Roadshow - August 8, 2019

AIM ImmunoTech News

Hemispherx Secures Corrections from Two Stock News Organizations Related to Their...

CEO Roadshow - August 2, 2019

AIM ImmunoTech News

Hemispherx Biopharma (NYSE:HEB) Initiated at Maxim with Buy and $8 Target

CEO Roadshow - June 14, 2019

AIM ImmunoTech News

Hemispherx Biopharma Announces Significant Progress in its Ampligen Ovarian Cancer Program

CEO Roadshow - May 1, 2019

AIM ImmunoTech News

Hemispherx Biopharma Announces Significant Progress in its Ampligen Pancreatic Cancer Program...

CEO Roadshow - March 13, 2019

AIM ImmunoTech News

Hemispherx Biopharma Updates the Terms of Previously Announced Rights Offering and...

CEO Roadshow - February 27, 2019

AIM ImmunoTech News

Hemispherx Biopharma Announces Commencement of a New 45 Subject Clinical Trial...

CEO Roadshow - February 11, 2019

AIM ImmunoTech News

Hemispherx Biopharma Announces Key Dates and Timeline for Stockholder Participation in...

CEO Roadshow - February 6, 2019

AIM ImmunoTech News

Hemispherx Biopharma Announces IRB Approval of Clinical Study in Metastatic Triple...

CEO Roadshow - January 8, 2019

AIM ImmunoTech News

Hemispherx Biopharma Inc. Announces Advancement in Expanded Access Program for Ampligen...

CEO Roadshow - January 2, 2019

12 Page 1 of 2

- Advertisement -

LATEST NEWS

CEORoadshow 2021 Webinar Series Presents Genprex, Inc. (NASDAQ: GNPX)

CEO Roadshow - April 19, 2021

U.S. Gold Corp. Releases Additional Drill Results and is on Track to Complete Pre-Feasibility...

CEO Roadshow - April 6, 2021

Pacific Green Enters Exclusive Agreement to Develop 1.1GW of UK Based Battery Energy Storage...

CEO Roadshow - March 18, 2021

Company eyeing potential gold, copper mine near Curt Gowdy State Park

CEO Roadshow - February 19, 2021

LATEST INTERVIEWS

CEORoadshow Interview with Andrew Fox, Founder, and CEO of Charge...

CEO Roadshow - April 20, 2021

CEORoadshow Interviews

In this episode of CEO Roadshow, we are joined by Andrew Fox, Founder, and CEO of Charge Enterprises. Charge Enterprises is a portfolio of...

MiningTechnica Interviews President & CEO of U.S. Gold Corp., George Bee

CEO Roadshow - April 6, 2021

CEORoadshow Interviews

In this episode of MiningTechnica we are joined by Mr. George Bee, President of US Gold Corp, ticker USAU, a publicly-traded, U.S. focused gold...